Early detection and aggressive treatment of prostate cancer: groping in the dark
- PMID: 11089719
- PMCID: PMC1495598
- DOI: 10.1046/j.1525-1497.2000.00816.x
Early detection and aggressive treatment of prostate cancer: groping in the dark
Comment on
-
Using the free-to-total prostate-specific antigen ratio to detect prostate cancer in men with nonspecific elevations of prostate-specific antigen levels.J Gen Intern Med. 2000 Oct;15(10):739-48. doi: 10.1046/j.1525-1497.2000.90907.x. J Gen Intern Med. 2000. PMID: 11089718 Free PMC article.
References
-
- Fowler FJ, Bin L, Collins MM, et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med. 1998;104:526–32. - PubMed
-
- Woloshin S, Schwartz L. The U.S. Postal Service and cancer screening-stamps of approval? N Engl J Med. 1999;340:884–7. - PubMed
-
- Tarone R, Chu K, Brawley O. Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates. Epidemiology. 2000;11:167–70. - PubMed
-
- Bartsch G, Horninger W, Klocker H, et al. Decrease in prostate cancer mortality following introduction of prostate specific antigen (PSA) screening in the federal state of Tyrol, Austria. J Urol. 2000;163:88. - PubMed
-
- Brawley O. Prostate carcinoma incidence and patient mortality. The effects of screening and early detection. Cancer. 1997;80:1857–63. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical